FI912623A7 - Farmakologiskt aktiva foereningar med verkan pao det centrala nervsystemet. - Google Patents

Farmakologiskt aktiva foereningar med verkan pao det centrala nervsystemet. Download PDF

Info

Publication number
FI912623A7
FI912623A7 FI912623A FI912623A FI912623A7 FI 912623 A7 FI912623 A7 FI 912623A7 FI 912623 A FI912623 A FI 912623A FI 912623 A FI912623 A FI 912623A FI 912623 A7 FI912623 A7 FI 912623A7
Authority
FI
Finland
Prior art keywords
nervsystemet
farmakologiskt
verkan
aktiva
foereningar
Prior art date
Application number
FI912623A
Other languages
English (en)
Finnish (fi)
Other versions
FI912623A0 (fi
Inventor
Michael John Leach
Malcolm Stuart Nobbs
Ramachandran Iyer
Clive Leonard Yeates
Philip Alan Skone
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to FI961410A priority Critical patent/FI961410A0/fi
Publication of FI912623A0 publication Critical patent/FI912623A0/fi
Publication of FI912623A7 publication Critical patent/FI912623A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
  • Paper (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
FI912623A 1990-06-01 1991-05-31 Farmakologiskt aktiva foereningar med verkan pao det centrala nervsystemet. FI912623A7 (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI961410A FI961410A0 (fi) 1990-06-01 1991-05-31 Farmakologisesti aktiivisia keskushermostoon vaikuttavia yhdisteitä

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909012316A GB9012316D0 (en) 1990-06-01 1990-06-01 Pharmacologically active cns compounds

Publications (2)

Publication Number Publication Date
FI912623A0 FI912623A0 (fi) 1991-05-31
FI912623A7 true FI912623A7 (fi) 1991-12-02

Family

ID=10676964

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912623A FI912623A7 (fi) 1990-06-01 1991-05-31 Farmakologiskt aktiva foereningar med verkan pao det centrala nervsystemet.

Country Status (25)

Country Link
EP (2) EP0679645A1 (enExample)
JP (1) JPH06340634A (enExample)
KR (1) KR920000733A (enExample)
AT (1) ATE141263T1 (enExample)
AU (2) AU652753B2 (enExample)
CA (1) CA2043640A1 (enExample)
CZ (1) CZ281070B6 (enExample)
DE (1) DE69121317T2 (enExample)
DK (1) DK0459819T3 (enExample)
ES (1) ES2093078T3 (enExample)
FI (1) FI912623A7 (enExample)
GB (1) GB9012316D0 (enExample)
GR (1) GR3021237T3 (enExample)
HU (2) HUT58707A (enExample)
IE (1) IE911861A1 (enExample)
IL (2) IL113599A (enExample)
MY (2) MY109958A (enExample)
NO (1) NO180375C (enExample)
NZ (3) NZ238360A (enExample)
PL (2) PL170373B1 (enExample)
PT (1) PT97827B (enExample)
RU (1) RU2091374C1 (enExample)
SK (1) SK278444B6 (enExample)
TW (1) TW224460B (enExample)
ZA (1) ZA914165B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
CH685978A5 (fr) * 1991-01-30 1995-11-30 Wellcome Found Comprimes dispersables dans l'eau.
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
JPH08504798A (ja) * 1992-12-18 1996-05-21 ザ ウエルカム ファウンデーション リミテッド 酵素阻害薬としての，ピリミジン，ピリジン，プテリジノンおよびインダゾール誘導体
GB9226377D0 (en) * 1992-12-18 1993-02-10 Babbedge Rachel C Pharmaceutical compositions
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
GB9319341D0 (en) * 1993-09-17 1993-11-03 Wellcome Found Novel process
FR2741879A1 (fr) * 1995-12-05 1997-06-06 Esteve Labor Dr Derives de fluorophenyl-triazines et pyrimidines, leur preparation et leur application en tant que medicament
US6440965B1 (en) * 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
MY123528A (en) 1999-09-16 2006-05-31 Mitsubihsi Tanabe Pharma Corp Aromatic nitrogen-containing 6-membered cyclic compounds.
WO2001062233A2 (en) * 2000-02-25 2001-08-30 F. Hoffmann La Roche Ag Adenosine receptor modulators
US7273868B2 (en) 2000-04-28 2007-09-25 Tanabe Seiyaku Co., Ltd. Pyrazine derivatives
MXPA02010693A (es) 2000-04-28 2003-03-10 Tanabe Seiyaku Co Compuestos ciclicos.
WO2002008205A1 (en) * 2000-07-24 2002-01-31 Krenitsky Pharmaceuticals, Inc. Substituted 5-alkynyl pyrimidines having neurotrophic activity
MXPA03007623A (es) 2001-02-26 2003-12-04 Tanabe Seiyaku Co Derivado de piridopirimidina o naftiridina.
PL372390A1 (en) * 2002-02-05 2005-07-25 Novo Nordisk A/S Novel aryl- and heteroarylpiperazines
TW200637556A (en) * 2005-01-31 2006-11-01 Basf Ag Substituted 5-phenyl pyrimidines I in therapy
EP1902028A2 (en) 2005-07-04 2008-03-26 Novo Nordisk A/S Histamine h3 receptor antagonists
CA2653062A1 (en) 2006-05-23 2007-11-29 Transtech Pharma, Inc. 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
ATE538116T1 (de) 2006-05-29 2012-01-15 High Point Pharmaceuticals Llc 3-(1,3-benyodioxol-5-yl)-6- (4- cyclopropylpiperazin-1-yl)-pyridazin, dessen salze und solvate und dessen verwendung als histamin-h3-rezeptorantagonist
EP2014656A3 (en) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
US9073947B2 (en) 2011-06-10 2015-07-07 Merck Patent Gmbh Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
JO3517B1 (ar) 2014-01-17 2020-07-05 Novartis Ag ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
WO2015107493A1 (en) * 2014-01-17 2015-07-23 Novartis Ag 1 -pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and and compositions thereof for inhibiting the activity of shp2
CA3023216A1 (en) 2016-06-14 2017-12-21 Novartis Ag Compounds and compositions for inhibiting the activity of shp2
RU2769132C2 (ru) 2017-01-10 2022-03-28 Новартис Аг Фармацевтическая комбинация, содержащая ингибитор alk и ингибитор shp2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE518622A (enExample) *
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä
US5136080A (en) * 1989-12-04 1992-08-04 Burroughs Wellcome Co. Nitrile compounds

Also Published As

Publication number Publication date
NO180375C (no) 1997-04-09
PT97827B (pt) 1998-10-30
FI912623A0 (fi) 1991-05-31
HUT58707A (en) 1992-03-30
MY109958A (en) 1997-10-31
NZ248501A (en) 1997-03-24
IL113599A0 (en) 1995-08-31
DE69121317D1 (de) 1996-09-19
NO912100D0 (no) 1991-05-31
EP0459819B1 (en) 1996-08-14
HU211649A9 (en) 1995-12-28
PL170373B1 (pl) 1996-12-31
IE911861A1 (en) 1991-12-04
EP0679645A1 (en) 1995-11-02
PL166656B1 (pl) 1995-06-30
CZ281070B6 (cs) 1996-06-12
AU7809791A (en) 1991-12-05
JPH06340634A (ja) 1994-12-13
ZA914165B (en) 1993-03-01
KR920000733A (ko) 1992-01-29
SK278444B6 (en) 1997-05-07
ATE141263T1 (de) 1996-08-15
CS164391A3 (en) 1992-02-19
EP0459819A3 (en) 1992-03-11
RU2091374C1 (ru) 1997-09-27
AU680252B2 (en) 1997-07-24
HU911826D0 (en) 1991-12-30
IL98330A0 (en) 1992-06-21
NZ272001A (en) 1997-03-24
CA2043640A1 (en) 1991-12-02
AU6745594A (en) 1994-09-15
AU652753B2 (en) 1994-09-08
DE69121317T2 (de) 1997-01-02
NZ238360A (en) 1997-03-24
EP0459819A2 (en) 1991-12-04
DK0459819T3 (da) 1996-09-02
MY136248A (en) 2008-08-29
NO912100L (no) 1991-12-02
PT97827A (pt) 1992-03-31
TW224460B (enExample) 1994-06-01
IL113599A (en) 1997-09-30
NO180375B (no) 1996-12-30
GR3021237T3 (en) 1997-01-31
GB9012316D0 (en) 1990-07-18
ES2093078T3 (es) 1996-12-16
IL98330A (en) 1996-10-31

Similar Documents

Publication Publication Date Title
FI912623A7 (fi) Farmakologiskt aktiva foereningar med verkan pao det centrala nervsystemet.
FI912621L (fi) Farmakologiskt aktiva foereningar med verkan pao det centrala nervsystemet.
FI931627L (fi) Foerfarande foer producering av tecken pao diamanter
FI931773A0 (fi) Pao en masspektrometer baserat kontinuerligt utslaeppsoevervakningssystemfoer maetning av roekgaser fraon farligt avfall
FI920478L (fi) Polymer smoerjblandning med eftergarvande verkan foer moebellaeder med laog inbildning.
FI930681L (fi) Saerskilt foer granskning av registerplaotarna pao fordon avsedd oevervakningsanordning
FI895243A0 (fi) Koppling foer kompensering av verkan av yttre ljus pao infraroedkaensliga fototransistorer i kontaktrepresentationspaneler.
FI923702L (fi) Fosfoinositolglykanpeptid med insulinartad verkan
FI901957A0 (fi) Dipeptidderivat med enzyminhibiterande verkan.
FI932963A7 (fi) Anordning foer att minska storleken pao virke
FI912622L (fi) Farmakologiskt aktiva foereningar med verkan pao det centrala nervsystemet.
FI912079A7 (fi) Anordning foer att besdryka flytbara belekningsmassor pao loepande aemnesbanor.
FI915384A0 (fi) Polymeriseringskatalyt pao en baerare.
FI910567A0 (fi) Foerfarande foer foerhindrande av utslag pao mineraliska underlag.
FI894783L (fi) Substituerade aromatiska foereningar med verkan pao det centrala nervsystemet.
FI932055L (fi) Foerfarande foer betahaerdning av skyddshoeljet pao kaernbraensle
DE59105155D1 (de) Befestigungsvorrichtung.
FI925370L (fi) Peptider med insulinartad verkan
FI914692A0 (fi) Utloppsmunstycke med konvergerande utloppsroer pao ett offset-pumphus.
FI923964L (fi) Faestgoeringssystem foer synliga monteringsdelar pao fordon, speciellt motorfordon
FI911978L (fi) Peptider med bradykininantagonistisk verkan.
DE69107854D1 (de) Befestigungsvorrichtung.
FI911781A0 (fi) Herbicider med synergistisk verkan.
DE59103612D1 (de) Befestigungsvorrichtung.
DE69102548D1 (de) Befestigungsvorrichtung.

Legal Events

Date Code Title Description
FD Application lapsed